| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |